Northwest (NWBO) Rockets 173% In a Month

Northwest had been plunging to all-time lows again and again until this April when there was a clear signal for the next possible spike. Today NWBO is nearly reaching the $2 mark after skyrocketing from $0.70 per share.

This month the stock is sharply surging amid announcing a presentation about the phase 3 trial of DCVax-L Glioblastoma to be conducted at the NY Academy of Sciences. On Thursday NWBO grew 17.54% on 11.7 million volume while the stock market was turning red.

If the planned presentation positively impresses the scientists and students new external funds may flow into NWBO from various sources. Thus, the stock will likely soar again on May 11.

nwbo stock